News & Updates
Filter by Specialty:
How safe is long-term bimekizumab in plaque psoriasis patients?
Treatment with bimekizumab (BKZ) for over 3 years does not result in the occurrence of new adverse events (AEs), demonstrating its positive safety profile in patients with moderate-to-severe plaque psoriasis, as shown by a pooled analysis of five phase III/IIIb trials presented at EADV 2023.
How safe is long-term bimekizumab in plaque psoriasis patients?
24 Oct 2023
COVID shots hold up against Omicron XBB for youngest kids in SG
The monovalent mRNA vaccine helped stave off severe COVID-19 outcomes in children aged 1 to 4 years during the Omicron wave, as shown in a study from Singapore.
COVID shots hold up against Omicron XBB for youngest kids in SG
23 Oct 2023
Do alpha-1 receptor blockers help prevent COVID-19 hospitalization?
Frequent use of alpha-1 receptor blockers is neither harmful nor protective against the risk of uncomplicated or severe COVID-19 hospitalization, a study has shown.
Do alpha-1 receptor blockers help prevent COVID-19 hospitalization?
22 Oct 2023
Face mask use tied to cardiovascular symptoms
Use of face masks remains an effective method in preventing COVID-19 transmission, but a recent study in Singapore has found that wearing of face masks is also associated with more self-reported cardiovascular symptoms.
Face mask use tied to cardiovascular symptoms
20 Oct 2023
Beta strain-containing bivalent vaccine protects against various SARS-CoV-2 variants
A Beta variant-containing vaccine conferred protection against different SARS-CoV-2 variants, with an acceptable safety profile in adults <60 years, a phase III trial has shown.